VANCOUVER, BC / ACCESS Newswire / July 7, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:XPHYF)(FSE:4XT), a bioscience innovator specializing in advanced drug delivery systems ...

Randy Travis and Clay Walker saw the opportunity to have some fun and decided to make the most of it with a wheelchair race.

Rocky Mountain MS Clinic opened a location in Lehi this week, filling a gap in care for patients who have traveled hours or ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

Discover how the brain "eats" itself during a marathon, and how the recovery process opens doors to possible MS treatments.

Susan Blackborough was just 12 when she was diagnosed with multiple sclerosis and was told she would lose her ability to walk ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Multiple sclerosis sufferer Braylee Burnett, who turns 18 on Wednesday, learned she can once again resume infusions for her ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...

Valo Health Inc. has disclosed sphingosine 1-phosphate receptor 1 (S1P1 receptor; EDG1) agonists reported to be useful for the treatment of multiple sclerosis, psoriasis, amyotrophic lateral sclerosis ...